| Autor: |
Mònica Aparici, Mònica Bravo, Elena Calama, Vicente García-González, Teresa Domènech, Mònica Córdoba, Inés Roger, Julio Cortijo, Miriam Góngora-Benítez, Marta Paradís-Bas, Barry Collins, Andrew M. Davis, Fernando Albericio, Carlos Puig |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Biochemical pharmacology. 204 |
| ISSN: |
1873-2968 |
| Popis: |
LAS200813 is a novel bicyclic lipopeptide that activates Nrf2 by binding to Keap1, thereby antagonising the Keap1-Nrf2 protein-protein interaction. In this work we report the pharmacological characterization of LAS200813 in Nrf2-dependent translational preclinical models. LAS200813 binds to Keap1 with high affinity (ICsub50/sub: 0.73 nM) and is able to induce the translocation of Nrf2 to the nucleus. Furthermore, LAS200813 increases the expression of Nrf2 target genes in human bronchial epithelial cells (ECsub50/subof 96 and 70 nM for srxn1 and nqo1, respectively). Similarly, the intratracheal administration of LAS200813 to rats increases the expression of Nrf2-dependent genes in lung tissue, an effect that lasts for a few hours. Moreover, in cells exposed to cigarette smoke, LAS200813 shows an antioxidant effect by increasing the production of glutathione and prevents cellular apoptosis. In conclusion, the results described herein demonstrate that LAS200813 is a potent non-electrophilic Nrf2-activating peptide designed to be administered by inhaled route which may be a potential therapeutic strategy for respiratory diseases driven by oxidative stress. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect